Holen Sie sich die Stockscreener-App
1,030.05
0.82%
8.35
Handel nachbörslich:
1029.00
-1.05
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Major Shareholder Sells Millions in Eli Lilly Stock! - TipRanks
Is Eli Lilly and Company stock positioned for secular growth2025 Trading Volume Trends & Fast Moving Trade Plans - newser.com
Top Research Reports for Microsoft, Amazon.com & Eli Lilly - Nasdaq
Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It’s a Worry for the Stocks. - Barron's
Senator questions Lilly CEO on details of Trump deal for weight loss drugs - Endpoints News
Gallego demands answers on Eli Lilly’s deal with Trump - The Hill
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? - Benzinga
Novo Nordisk (NVO) and Eli Lilly (LLY) Cut Drug Prices to Enhance U.S. Accessibility - Somos Hermanos -
ABL Bio Enters $2.6 Billion Multi-Program Collaboration Agreement with Eli Lilly - PharmExec.com
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
JPMorgan raises Eli Lilly stock price target to $1,150 on obesity drug outlook - Investing.com Canada
Eli Lilly's (LLY) Donanemab Gains Approval in India - GuruFocus
Lilly to participate in Citi's 2025 Global Healthcare Conference - MarketScreener
Jim Cramer Comments On Eli Lilly (LLY)’s Shares After Pfizer CEO’s Remarks - MSN
JPMorgan Adjusts PT on Eli Lilly and Co. to $1,150 From $1,050, Maintains Overweight Rating - MarketScreener
The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company - The Wall Street Journal
Eli Lilly gets drug regulator nod for Alzheimer's disease medication - BusinessLine
Eli Lilly Could Be Next Company to Split Its Stock - MSN
TD Cowen Maintains Buy on Eli Lilly (LLY) After Government Deal - Insider Monkey
The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum - Yahoo Finance
Eli Lilly get nod from CDSCO for it Alzheimer’s drug Donanemab - The Economic Times
Lilly Stock Continues Its Winning Ways - The Wall Street Journal
Eli Lilly receives approval for Alzheimer’s drug in India By Investing.com - Investing.com Nigeria
Eli Lilly receives approval for Alzheimer’s drug in India - Investing.com
CDSCO grants marketing authorization for Eli Lilly and Company (India) drug for adults in early stages of Alzheimeras - MarketScreener
Major Shareholder Makes a Massive Move with Eli Lilly Stock - TipRanks
Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy? - The Motley Fool
Eli Lilly (LLY) Enters $2.6B Deal with ABL Biotech for Antibody Development - GuruFocus
Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring - Benzinga
Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds - MarketScreener
Bloomberg Intelligence: Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay in US - Bloomberg.com
Why Eli Lilly will win the GLP-1 race – plus, a promising sign for Boeing investors - CNBC
Novo Nordisk cuts Ozempic price in weight loss war with Eli Lilly - qz.com
How the Lilly-Adverum deal came together; Captain T Cell reels in €20M - Endpoints News
Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay in US - Bloomberg.com
Eli Lilly Stock (LLY) Falls as Rival Novo Nordisk Cuts Weight-Loss Drug Prices - TipRanks
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock - Yahoo Finance
Eli Lilly: This Breakout Rally Has More Room To Run (NYSE:LLY) - Seeking Alpha
Lilly Bets More Than $2.6B for South Korea Biotech’s Bispecific Antibody Platform - BioSpace
Eli Lilly (LLY) Faces Pricing Competition with Novo Nordisk's Dr - GuruFocus
Novo Nordisk cuts Wegovy, Ozempic direct-to-user prices to match Eli Lilly’s Zepbound (NVO:NYSE) - Seeking Alpha
Eli Lilly’s Billion-Dollar Expansion Strategy Fuels Record Growth - AD HOC NEWS
Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients - Bloomberg.com
H.C. Wainwright downgrades Adverum stock to Neutral following Eli Lilly acquisition - Investing.com India
Mizuho reiterates Outperform rating on Adverum stock amid Eli Lilly deal - Investing.com Canada
Eli Lilly Partners with NVIDIA to build pharma-focused AI supercomputer - Cleanroom Technology
Deal With Eli Lilly Propels Founder Of Korean Biotech Firm Into Billionaire Ranks - Forbes
Lilly Goes Beyond Medicine with Indianapolis Gives - Indianapolis Monthly
Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch - Finviz
ABL Bio CEO Lee says company will return to profit this year if Lilly upfront payment receivedCHOSUNBIZ - Chosun Biz
Eli Lilly’s trillion-dollar climb exposes Europe’s absence from top ranks of stock markets - The Irish Times
Eli Lilly Gains Momentum with Dual Regulatory Advances - AD HOC NEWS
Trump Strikes Deal with Lilly and Novo Nordisk, Slashing Prices of Weight-Loss Drugs - NAI500
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? - The Motley Fool
Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock - The Globe and Mail
Eli Lilly (LLY) Leads Healthcare Gains Amid Market Fluctuations - GuruFocus
Eli Lilly’s CEO Runs AI in Every Meeting: Pharma’s Bold Bet on Real-Time Intelligence - WebProNews
Eli Lilly's (LLY) "a Great Company," Says Jim Cramer - Finviz
Eli Lilly’s (LLY) “a Great Company,” Says Jim Cramer - Yahoo Finance
Eli Lilly Shares Surge as Oral Drug Pipeline Gains Momentum - AD HOC NEWS
0.21%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):